Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
0.8410
+0.0978 (13.16%)
At close: Nov 18, 2026, 4:00 PM EST
0.822998
-0.0180 (-2.14%)
Pre-market: Nov 19, 2026, 7:00 AM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $52.16 million as of November 18, 2026. It is the 29,348th most valuable company in the world and the 4,510th biggest in the United States. Its market cap has decreased by 35.05% in one year.
Market Cap
52.16M
Enterprise Value
49.34M
1-Year Change
-35.05%
Global Rank
Country Rank
#4,510 United States
Category
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $52.16M, a decrease of -16.55%. That is a compound annual growth rate of -2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 52.16M | -43.12% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 53.66M |
| Impact BioMedical | 53.31M |
| Xilio Therapeutics | 51.99M |
| Verrica Pharmaceuticals | 51.88M |
| Heron Therapeutics | 51.87M |
| Azora Therapeutics | 51.86M |
| Spero Therapeutics | 51.01M |
| Gain Therapeutics | 50.09M |